Pluribus Labs’s Arconic Corporation ARNC Stock Holding History

Pluribus Labs’s Portfolio ARNC Stock Details ARNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,479	Closed	-$313K	–	238
2021 Q4	$313K	Buy	+9,479	New	+$293K	0.33%	129

Other funds holding ARNC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pluribus Labs's ARNC Position: Q1 2022 in Review

Pluribus Labs sold out of Arconic Corporation (ARNC) in Q1 2022, closing a stake of 9,479 shares — an estimated $313K sold.

Pluribus Labs first reported a position in ARNC in Q4 2021 and held it in 1 quarter. The position peaked at $313K in Q4 2021. 292 funds tracked by Wall St. Rank hold ARNC as of Q1 2022.

Pluribus Labs reported no remaining Arconic Corporation position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 9,479 Arconic Corporation shares in Q1 2022, an estimated $313K.
Pluribus Labs first reported a position in Arconic Corporation in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Arconic Corporation position peaked at $313K in Q4 2021.
292 funds tracked by Wall St. Rank held Arconic Corporation as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.